Pharmalittle: We’re reading about Cigna biosimilar plans, a Vertex deal in South Africa, and more
Cigna plans to make copies of AbbVie’s Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
Cigna plans to make copies of AbbVie’s Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
In this interview, Browning discusses his team’s trial data and the implications of the FDA’s decision to accept the supplemental new drug application for tapinarof…
New CMS rule requires home-based care providers use 80 percent of their Medicaid reimbursements toward compensation for their workers.
STAT Breakthrough Summit West is one-day event designed to break down silos across health and medicine by bringing together leaders, entrepreneurs, policymakers, patient advocates —…
The April 2024 cardiology month in review spotlights FDA news and top updates from the American College of Cardiology 2024 Scientific Session.
Subscribe to STAT+ and stay up-to-date on the latest trends and ground breaking discoveries in cancer research.
Cohen tells Milken Institute Global Conference “data is absolutely critical if we’re going to protect the health of this country” during viral outbreaks.
The U.S. FDA’s panel of independent advisers will on June 4 deliberate whether they should recommend approval for the first MDMA-assisted therapy for post-traumatic stress…
AUA 2024 comparison of mitomycin C vs BCG treatment, non-muscle invasive bladder cancer, International Bladder Cancer Group (IBCG), Kaplan-Meier analysis.
Latticework Capital Management said it exceeded its goal for its second healthcare fund.
Indian generic drugmaker Lupin reported a smaller-than-expected rise in fourth-quarter profit on Monday, as higher raw material costs more than offset strong demand for its…